Phase-3 trials of Oxford Astra Zeneca Covid-19 vaccine candidate will commence shortly
The Brihanmumbai Municipal Corporation (BMC) has finished the second phase clinical trials of the Covid-19 vaccine candidate led by Oxford-AstraZeneca. BMC further plans to commence third phase clinical trials once the first batch of volunteers have finished 28 days post consuming the vaccine. The vaccine candidate, termed as COVSHIELD, was administered on total count of…